Navigation Links
Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
Date:5/29/2008

SWARTZ CREEK, Mich., May 29 /PRNewswire/ -- Diplomat Specialty Pharmacy, a leader in specialty pharmacy services, disease management (DM) and drug therapy management (DTM) announced today that their specialty pharmacy was one of 3 sponsors of the National Managed Care Roundtable (NMCRT) held this month in Dallas, Texas. This forum brought 30 industry executives from top consulting and managed care organizations together to review and improve on the current offerings and directions of specialty pharmacy and other critical business segments.

"With our advisors high in the managed care hierarchy, their opinions carry weight in their organizations and within the managed care marketplace," stated Jim Smeeding, President of NMCRT. "I believe that Diplomat offered services that go above and beyond the usual expectations for a specialty pharmacy."

"Managed Care executives provided us with invaluable insights at the meeting. Their reviews will benefit us greatly as we continue to expand Diplomat on a national level," stated Phil Hagerman, President and CEO of Diplomat. "Consistent messages from the group included: the importance of patient care outcome reporting, the need for increased price transparency, the benefits of shared risk for disease management, and the need to maintain a high level of service to patients on specialty medications."

"The feedback from managed care organizations confirmed that specialty pharmacy is still a high priority within the pharmacy and medical benefits," stated Dr. Atheer Kaddis, Diplomat's Vice President of Managed Markets. "It also confirmed to us that there are very few, if any, successful care management models addressing kidney disease today. The programs presented by Diplomat Specialty Pharmacy to address specialty pharmacy and kidney disease were well received by managed care organizations and we are excited about future potential opportunities to work with managed care organizations in these priority areas."

Smeeding added that, "Diplomat was very well received by our advisors -- clearly there is an unmet need for managing these high cost, high acuity patients that Diplomat services. The feedback from our advisors should allow Diplomat to continue to expand their offerings with greater insights into what the marketplace demands and desires."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

About NMCRT

Established in 2006, National Managed Care Roundtable LLC (NMCRT) provides innovative, informational interchange programs to address the business and clinical issues of medical directors and pharmacy directors from health plans, pharmacy benefit management companies and physician groups. Typical sponsors include pharmaceutical companies, medical device, disease management and other companies offering products and services of interest to our advisors.

For more information contact:

Alecia Greilich

agreilich@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
10. Pharmacyclics Announces It Received Nasdaq Notification
11. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider of ... businesses of all types to ensure cleanliness, distancing and occupancy with its patent pending ... Space™ enabled business will provide a health performance index system that scores all aspects ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Security Industry ... its strong opposition to the recently introduced bicameral Facial Recognition and Biometric ... most federal use of nearly all biometric and related image analytics technologies, incorrectly ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... offering an Amniosomes special offer. This includes buy three, get the fourth unit ... (888) 568-6909. , Amniotic derived exosomes, known as exosomes, have been a game ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace ... is to join forces to radically prolong life and find a way (medicine or ... period. This project was supported by various scientists from all over the world, doctors, ...
Breaking Biology Technology:
(Date:5/30/2020)... JOSE, Calif. (PRWEB) , ... May 29, 2020 ... ... and enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. ... the FDA. It can measure systolic heart function, which has been clinically ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... announced a new enzyme solution for adjunct liquefaction: AMYLEX® 6T. The innovative ... ability to expand into new segments with locally-sourced raw materials, improve productivity, ...
(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is in ... SARS-CoV-2, the virus that causes COVID-19. , The LamPORE assay is designed ... sample numbers, to very large numbers of samples. Hardware and reagents sit outside ...
Breaking Biology News(10 mins):